Frequently asked questions
The following questions are often asked by people contacting Retina UK.
Search
Search results
Research brings hope for the future
“All the promising research makes you feel like there is light at the end of that very dark tunnel after all.”
Fundraising FAQs
Fancy fundraising for Retina UK? Here’s a few pointers to help get you started.
Positive early findings from ProQR trial of USH2A therapy
Biotechnology company ProQR has announced encouraging results from its early analysis of the phase 1/2 trial of QR-421a, an innovative approach to treating sight loss caused by mutations in a particular section of the USH2A gene.
e-Newsletter August 2023
Our monthly e-Newsletter featuring the latest updates from Retina UK. Subscribe now to receive these updates directly to your email.
Tough Mudder 2025
With various events to choose from in 2025, these hugely popular events are back for another year! Round up your friends, family members and colleagues and join #TeamRetinaUK for a fun day out!
Inflatable Assault Courses 2025
With various events to choose from in 2025, these hugely popular events are back for another year! Round up your friends, family members and colleagues and join #TeamRetinaUK for a fun day out!
Bungee Jumping
With various locations to choose from in 2025, these hugely popular jumps are back for another year! Join #TeamRetinaUK for a fun day out in 2025.
Retinitis Pigmentosa Awareness Month 2025
February is Retinitis Pigmentosa Awareness Month and we'd love you to get involved to enhance the work of Retina UK, as we continue to support those who are living with retinitis pigmentosa and other inherited sight loss conditions.
ProQR announces agreement with Laboratoires Théa for inherited retinal disease programmes
Biotechnology company ProQR has announced that two of its RNA therapy development programmes for inherited sight loss are being acquired by Laboratoires Théa, a company specialising in eye care products.